Breaking News

LEO Pharma, ICON Partner to Advance Clinical Trials in Dermatology

Will leverage both fully outsourced and functional outsourcing models in a tailored and flexible hybrid approach.

LEO Pharma, a global leader in medical dermatology, and ICON plc, entered into a strategic partnership that will enable LEO Pharma to scale clinical trial execution that is patient-centric and cost effective, to support the company’s clinical portfolio. The partnership will operate under the acronym of PACE, reflecting the requirement to move quickly to address clinical development challenges. It also represents LEO Pharma and ICON’s shared values of Passion, Agility, Communication and Excell...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters